Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OTC Monograph Reform, User Fee Legislation Coming 'Any Day' – CHPA

Executive Summary

Imminent OTC monograph reform legislation signals an agreement between industry and FDA on details of a proposal, which also includes a potential user fee program. CHPA also is hopeful for legislation restoring direct OTC drug purchases with pre-tax savings accounts.


Related Content

Codeine Concerns Cough Up FDA's OTC Monograph Problems
Codeine Concerns Cough Up FDA's OTC Monograph Problems
It’s Complicated: Health Care Act Simplifies Buying OTCs With Pre-Tax Accounts
Direct OTC Purchases With Pre-Tax Accounts Swing On ACA Change, Not Repeal
OTC Drug Industry Could Stand To Gain With 'Pragmatist' In White House
Sunscreen Group Remains Cloudy About FDA's Ingredient Evaluations
OTC Monograph User Fees: FDA-Industry Talks Move From Basics To Details
OTC Monograph User Fees Inspire Wary Support From Industry
FDA Floats OTC Monograph Overhaul To Be “More Agile And Responsive”
Fate Of OTCs In Health Savings Accounts Rests In Capitol Hill Negotiations





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts